As of 2025-09-17, the Relative Valuation of Citius Pharmaceuticals Inc (CTXR) is (42.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.17 USD, the upside of Citius Pharmaceuticals Inc based on Relative Valuation is -3726.6%.
The range of the Relative Valuation is (40.71) - (44.36) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 18.7x | 17.8x |
| Forward P/E multiples | 17.2x - 19.4x | 18.0x |
| Fair Price | (40.71) - (44.36) | (42.43) |
| Upside | -3579.9% - -3891.4% | -3726.6% |
| Date | P/E |
| 2025-09-11 | -0.50 |
| 2025-09-10 | -0.51 |
| 2025-09-09 | -0.51 |
| 2025-09-08 | -0.52 |
| 2025-09-05 | -0.52 |
| 2025-09-04 | -0.49 |
| 2025-09-03 | -0.52 |
| 2025-09-02 | -0.54 |
| 2025-08-29 | -0.56 |
| 2025-08-28 | -0.59 |
| 2025-08-27 | -0.58 |
| 2025-08-26 | -0.56 |
| 2025-08-25 | -0.53 |
| 2025-08-22 | -0.57 |
| 2025-08-21 | -0.52 |
| 2025-08-20 | -0.52 |
| 2025-08-19 | -0.52 |
| 2025-08-18 | -0.58 |
| 2025-08-15 | -0.56 |
| 2025-08-14 | -0.55 |
| 2025-08-13 | -0.54 |
| 2025-08-12 | -0.55 |
| 2025-08-11 | -0.53 |
| 2025-08-08 | -0.52 |
| 2025-08-07 | -0.54 |
| 2025-08-06 | -0.54 |
| 2025-08-05 | -0.57 |
| 2025-08-04 | -0.59 |
| 2025-08-01 | -0.54 |
| 2025-07-31 | -0.58 |
| 2025-07-30 | -0.59 |
| 2025-07-29 | -0.62 |
| 2025-07-28 | -0.65 |
| 2025-07-25 | -0.71 |
| 2025-07-24 | -0.71 |
| 2025-07-23 | -0.70 |
| 2025-07-22 | -0.62 |
| 2025-07-21 | -0.61 |
| 2025-07-18 | -0.65 |
| 2025-07-17 | -0.67 |
| 2025-07-16 | -0.63 |
| 2025-07-15 | -0.69 |
| 2025-07-14 | -0.71 |
| 2025-07-11 | -0.66 |
| 2025-07-10 | -0.69 |
| 2025-07-09 | -0.75 |
| 2025-07-08 | -0.82 |
| 2025-07-07 | -0.89 |
| 2025-07-03 | -0.93 |
| 2025-07-02 | -0.89 |